PDT Partners’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-158,384
| Closed | -$3.68M | – | 745 |
|
|
2024
Q2 | $3.68M | Hold |
158,384
| – | – | 0.35% | 72 |
|
|
2024
Q1 | $3.25M | Buy |
158,384
+125,484
| +381% | +$2.57M | 0.31% | 98 |
|
|
2023
Q4 | $706K | Buy |
+32,900
| New | +$706K | 0.08% | 349 |
|
|
2022
Q4 | – | Sell |
-30,588
| Closed | -$939K | – | 697 |
|
|
2022
Q3 | $939K | Sell |
30,588
-5,753
| -16% | -$177K | 0.14% | 241 |
|
|
2022
Q2 | $1.07M | Buy |
36,341
+18,491
| +104% | +$544K | 0.09% | 372 |
|
|
2022
Q1 | $574K | Buy |
+17,850
| New | +$574K | 0.05% | 538 |
|
|
2021
Q4 | – | Sell |
-15,200
| Closed | -$767K | – | 902 |
|
|
2021
Q3 | $767K | Buy |
15,200
+10,466
| +221% | +$528K | 0.06% | 397 |
|
|
2021
Q2 | $371K | Sell |
4,734
-17,531
| -79% | -$1.37M | 0.02% | 574 |
|
|
2021
Q1 | $1.27M | Buy |
22,265
+4,552
| +26% | +$260K | 0.09% | 326 |
|
|
2020
Q4 | $1.48M | Sell |
17,713
-54,224
| -75% | -$4.54M | 0.1% | 271 |
|
|
2020
Q3 | $2.58M | Buy |
71,937
+13,537
| +23% | +$485K | 0.17% | 191 |
|
|
2020
Q2 | $1.41M | Sell |
58,400
-18,300
| -24% | -$442K | 0.1% | 242 |
|
|
2020
Q1 | $1.34M | Buy |
76,700
+38,797
| +102% | +$679K | 0.11% | 194 |
|
|
2019
Q4 | $660K | Sell |
37,903
-1,409
| -4% | -$24.5K | 0.04% | 361 |
|
|
2019
Q3 | $602K | Buy |
39,312
+28,092
| +250% | +$430K | 0.04% | 325 |
|
|
2019
Q2 | $233K | Buy |
+11,220
| New | +$233K | 0.01% | 357 |
|